157 related articles for article (PubMed ID: 37456890)
21. Ferroptosis-related gene signature predicts prognosis and immunotherapy in glioma.
Wan RJ; Peng W; Xia QX; Zhou HH; Mao XY
CNS Neurosci Ther; 2021 Aug; 27(8):973-986. PubMed ID: 33969928
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment.
Ren J; Yang J; Na S; Wang Y; Zhang L; Wang J; Liu J
Front Immunol; 2022; 13():998653. PubMed ID: 36211436
[TBL] [Abstract][Full Text] [Related]
23. A Novel Prognostic Pyroptosis-Related Gene Signature Correlates to Oxidative Stress and Immune-Related Features in Gliomas.
Zeng S; Li W; Ouyang H; Xie Y; Feng X; Huang L
Oxid Med Cell Longev; 2023; 2023():4256116. PubMed ID: 36778205
[TBL] [Abstract][Full Text] [Related]
24. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
Zhou S; Lu Y; Chen Y; Gan W
Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108
[TBL] [Abstract][Full Text] [Related]
25. An immunogenic cell death-related classification predicts response to immunotherapy and prognosis in triple-negative breast cancer.
Cheng XY; Liang Y; Zhang HF; Qian FZ; Sun XH; Liu XA
Am J Transl Res; 2023; 15(4):2598-2609. PubMed ID: 37193173
[TBL] [Abstract][Full Text] [Related]
26. Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer.
Cao X; Zhou X; Chen C; Wang Z; Sun Q
Front Cell Dev Biol; 2022; 10():962389. PubMed ID: 36393842
[TBL] [Abstract][Full Text] [Related]
27. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
28. Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma.
Zong Y; Cao Y; Zhang D; Guan X; Zhang F; Shen Z; Yin F
Sci Rep; 2023 Jun; 13(1):9118. PubMed ID: 37277499
[TBL] [Abstract][Full Text] [Related]
29. Identification of immunogenic cell death-associated subtypes and characterization of the tumor microenvironment in endometrial cancer.
Pan F; Luo Y; Wang L; Cheng Y; Bu W; Zhao X; Xu Y; Chen L; Wang H
J Gene Med; 2023 Jul; 25(7):e3495. PubMed ID: 36894497
[TBL] [Abstract][Full Text] [Related]
30. Machine learning-based construction of immunogenic cell death-related score for improving prognosis and response to immunotherapy in melanoma.
Li G; Zhang H; Zhao J; Liu Q; Jiao J; Yang M; Wu C
Aging (Albany NY); 2023 Apr; 15(7):2667-2688. PubMed ID: 37036471
[TBL] [Abstract][Full Text] [Related]
31. Establishment of an immunogenic cell death-related model for prognostic prediction and identification of therapeutic targets in endometrial carcinoma.
Liu Z; Huang Y; Zhang P; Yang C; Wang Y; Yu Y; Xiang H
Aging (Albany NY); 2024 Mar; 16(5):4920-4942. PubMed ID: 38461430
[TBL] [Abstract][Full Text] [Related]
32. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
33. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.
Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K
J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197
[TBL] [Abstract][Full Text] [Related]
34. An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma.
Wu Y; Li K; Liang S; Lou X; Li Y; Xu D; Wu Y; Wang Y; Cui W
Respir Res; 2023 May; 24(1):142. PubMed ID: 37259066
[TBL] [Abstract][Full Text] [Related]
35. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme.
Liu Z; Li W; You G; Hu Z; Liu Y; Zheng N
Open Med (Wars); 2023; 18(1):20230716. PubMed ID: 37273917
[TBL] [Abstract][Full Text] [Related]
36. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
37. Identification of a Fibroblast-Related Prognostic Model in Glioma Based on Bioinformatics Methods.
Zhang H; Huang Y; Yang E; Gao X; Zou P; Sun J; Tian Z; Bao M; Liao D; Ge J; Yang Q; Li X; Zhang Z; Luo P; Jiang X
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358948
[TBL] [Abstract][Full Text] [Related]
38. Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.
Yang J; Zhang J; Na S; Wang Z; Li H; Su Y; Ji L; Tang X; Yang J; Xu L
Front Immunol; 2022; 13():994034. PubMed ID: 36225939
[TBL] [Abstract][Full Text] [Related]
39. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
Ait Ssi S; Chraa D; El Azhary K; Sahraoui S; Olive D; Badou A
Front Immunol; 2021; 12():685213. PubMed ID: 34539626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]